Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (111-120 of 450) with videos related to

Pageof 45
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptorSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.
Journal of Neuroscience Research|July 21, 2004
Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cellsPhillip L Quirk, Suma Rao, Bryan L Roth, et al.
Biochemistry|January 22, 2008
Galpha-subunits differentially alter the conformation and agonist affinity of kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2007
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and BRuslan V Bikbulatov, Feng Yan, Bryan L Roth, et al.
Science Signaling|April 7, 2021
Biased ligands at opioid receptors: Current status and future directionsTao Che, Hemlata Dwivedi-Agnihotri, Arun K Shukla, et al.
Drug Discovery Today|December 5, 2023
Illuminating the understudied GPCR-omeSreeparna Majumdar, Yi-Ting Chiu, Julie E Pickett, et al.
Pharmacology & Therapeutics|March 29, 2011
Serotonin receptors and heart valve disease--it was meant 2BJoshua D Hutcheson, Vincent Setola, Bryan L Roth, et al.
European Journal of Pharmacology|December 9, 2003
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonistSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.
Nature Methods|January 8, 2013
A pharmacological organization of G protein-coupled receptorsHenry Lin, Maria F Sassano, Bryan L Roth, et al.
Molecular Pharmacology|April 16, 2003
The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalizationJohn A Gray, Anushree Bhatnagar, Vsevolod V Gurevich, et al.
Pageof 45

Showing results (111-120 of 450) with videos related to

Sort By:
Pageof 45
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptorSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.
Journal of Neuroscience Research|July 21, 2004
Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cellsPhillip L Quirk, Suma Rao, Bryan L Roth, et al.
Biochemistry|January 22, 2008
Galpha-subunits differentially alter the conformation and agonist affinity of kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2007
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and BRuslan V Bikbulatov, Feng Yan, Bryan L Roth, et al.
Science Signaling|April 7, 2021
Biased ligands at opioid receptors: Current status and future directionsTao Che, Hemlata Dwivedi-Agnihotri, Arun K Shukla, et al.
Drug Discovery Today|December 5, 2023
Illuminating the understudied GPCR-omeSreeparna Majumdar, Yi-Ting Chiu, Julie E Pickett, et al.
Pharmacology & Therapeutics|March 29, 2011
Serotonin receptors and heart valve disease--it was meant 2BJoshua D Hutcheson, Vincent Setola, Bryan L Roth, et al.
European Journal of Pharmacology|December 9, 2003
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonistSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.
Nature Methods|January 8, 2013
A pharmacological organization of G protein-coupled receptorsHenry Lin, Maria F Sassano, Bryan L Roth, et al.
Molecular Pharmacology|April 16, 2003
The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalizationJohn A Gray, Anushree Bhatnagar, Vsevolod V Gurevich, et al.
Pageof 45